InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,321.41
(
0.25%
)
US TECH 100
18,243.60
(
0.26%
)
Dow Jones
39,872.99
(
0.17%
)
Brent Oil
82.39
(
-0.07%
)
Bitcoin
70,131.25
(
0.00%
)
Post# of 251879
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Solar_Express

Send PM Follow Ignore
Followers 73
Posts 10908
Boards Moderated 1
Alias Born 10/02/2009

Solar_Express

Re: DewDiligence post# 228872

Saturday, 02/29/2020 5:49:02 PM

Saturday, February 29, 2020 5:49:02 PM

Post# of 251879
They have an S1 Filing for upgrading to the NASDAQ. The company has been around since 2000.

NuGenerex Immuno-Oncology has developed Ii-Key peptide vaccines against several potentially pandemic viruses, including bird flu, swine, flu, HIV, and a previous coronavirus, SARS. NGIO has an S1 Filing for the NASDAQ.

http://www.globenewswire.com/news-release/2020/02/27/1992098/0/en/Generex-Provides-Coronavirus-Update-Generex-Receives-Contract-from-Chinese-Partners-to-Develop-a-COVID-19-Vaccine-Using-Ii-Key-Peptide-Vaccines.html
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up